Ilan Oren

Mr. Oren has served as Vice President, Business Development at Dexcel Pharma, an international pharmaceutical company involved in the development, manufacture and commercialization of pharmaceuticals, since September 2011. He has been a member of the Axovant Board since March 2015. From 2007 to July 2011, he worked at L.E.K. Consulting, advising clients in the life sciences sector on corporate strategy, mergers and acquisitions, licensing and drug commercialization projects.

Mr. Oren currently serves as a director of Cynapsus Therapeutics Inc., a publicly traded specialty pharmaceutical company. He received his A.B. in Economics from Harvard College.